GSA Capital Partners’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-73,046
| Closed | -$362K | – | 1362 |
|
|
2021
Q4 | $362K | Buy |
+73,046
| New | +$362K | 0.05% | 807 |
|
|
2020
Q2 | – | Sell |
-16,800
| Closed | -$116K | – | 580 |
|
|
2020
Q1 | $116K | Sell |
16,800
-15,300
| -48% | -$106K | 0.03% | 874 |
|
|
2019
Q4 | $273K | Buy |
32,100
+3,500
| +12% | +$29.8K | 0.03% | 1086 |
|
|
2019
Q3 | $142K | Buy |
+28,600
| New | +$142K | 0.02% | 1233 |
|
|
2018
Q4 | – | Sell |
-13,801
| Closed | -$110K | – | 1301 |
|
|
2018
Q3 | $110K | Buy |
+13,801
| New | +$110K | 0.01% | 1548 |
|
|
2017
Q2 | – | Sell |
-50,697
| Closed | -$525K | – | 1639 |
|
|
2017
Q1 | $525K | Buy |
50,697
+15,464
| +44% | +$160K | 0.03% | 1067 |
|
|
2016
Q4 | $457K | Buy |
+35,233
| New | +$457K | 0.03% | 1047 |
|